Market Cap 262.95M
Revenue (ttm) 0.00
Net Income (ttm) -55.18M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.08
Volume 787,200
Avg Vol 819,318
Day's Range N/A - N/A
Shares Out 54.90M
Stochastic %K 3%
Beta -0.90
Analysts Strong Sell
Price Target $21.00

Company Profile

Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, develops immunotherapies for the cancer patients. It develops CAN-2409, which is in Phase III clinical trials for the treatment of prostate cancer; Phase II clinical trials for the treatment of pancreatic cancer; and Phase II clinical trials for the treatment of non-small cell lung cancer (NSCLC). The company is also developing CAN-3110, which is in Phase Ib clinical trials for the treatment of recurrent high-grade glioma. In...

Industry: Biotechnology
Sector: Healthcare
Phone: 617 916 5445
Address:
117 Kendrick Street, Suite 450, Needham, United States
MoneyGroupLLC
MoneyGroupLLC Sep. 14 at 1:13 AM
Enter: $CADL OCT 17 2025 $5 CALLS Buy in Price: $0.40 - $1.50 Take Profit: $0.52 Stop Bleeding: $0.35 ROI Potential: 29% Exit Within: 25 Minutes https://moneygroup.us/alerts
0 · Reply
fishmom
fishmom Sep. 13 at 7:01 PM
$CADL First and foremost, we are investors in a venture for both financial and humanitarium purposes. Thus, help people and have good investment for our relative futures. Self life is important as well as storage requirements and anything that helps these objectives are only relevant to those who are not consistent with the needs of being in the marketplace for stockholders. Patience for all potential expressions of the underlying medical processes are the most important, so be patient and wait for a partner news.
1 · Reply
Husky007
Husky007 Sep. 13 at 3:41 PM
$CADL here's another twist, so the company announced the results of prostate cancer trial December 11th 2024, if the management would have started the manufacturing process then they would have been able to file bla probably January 2026 12 month by the latest give and take 1 or 2 months. But for some reason we're delayed to December 2026 something doesn't add up here. So my theory is they're probably going for 18 months instead of 12 months and 6 months.
1 · Reply
telomerase
telomerase Sep. 13 at 2:51 PM
$CADL here's an interesting calculation... how many thousands of prostate cancer patients will die, have prostatectomies, be chemically castrated etc. because of the delay so that we can claim a longer shelf life on the vector? How about we just ship the product with a six month shelf life and then do a follow-up study to see how much it can be extended? Is the new FDA really this inflexible? Makary claims they aren't... maybe the expensive consultant firm could, you know, ask him.
1 · Reply
itsmejeremy
itsmejeremy Sep. 13 at 2:27 PM
$CADL welcome the newest bag holder 😂 please buy so he can exit without a loss
1 · Reply
Musky49
Musky49 Sep. 13 at 1:00 PM
$CADL Just a reminder that Jacob is pro Candel. The discussion that resulted was beneficial and demonstrated that we have a reputable leader at the helm.
2 · Reply
ShadowBull3745
ShadowBull3745 Sep. 13 at 11:23 AM
$CADL Excellent analysis by DiamondDog33. CADL cares about long term value for its shareholders (board and executive team are significant shareholders as well) and they know the steep value creation will come if they stay focused on execution for now. BP cares about assets that are completely derisked and they are willing to pay much more after approval. It’s obvious what the best strategy is for both CADL and BP.
2 · Reply
deporte1800
deporte1800 Sep. 13 at 9:47 AM
$CADL There are two short-term options regarding the share price: - That PBM attempts to raise the share price in order to execute the warrants before November 13. - Or that large shareholders and institutions keep the share price very low to prevent PBM from exercising the warrants. All of this may have been agreed upon in advance, which is why the $15 million offer was made weeks ago. PBM, Fidelity, the CEO, and other Candel directors accepted the offer at a price of $4.67, with the intention of not diluting the more than 6 million warrants that PBM would be entitled to exercise if certain prices are reached or a purchase offer is made by a BP. We will soon know the planned strategy, so stay tuned!
1 · Reply
DiamondDog33
DiamondDog33 Sep. 13 at 3:25 AM
$CADL PREDICTION- THE JEFFRIES 2025 LONDON Health conference is Nov 18-20 ......Looking for them to ((Initiate))< with similar targets to Cantor Citi Zacks,HWC 19-25 based on approval !!!!! LONG TERM VAL ...In addition they will see the GLIO DATA ...Falls in line with the ER report timeline as well .... 4Q back to rising 50/200 - low 5.86 -6.45.. loading 30 RSI fists over sub5 we shall see if i nail this timing for SWING shrs lot<.
0 · Reply
DiamondDog33
DiamondDog33 Sep. 13 at 12:22 AM
$CADL JUNE is now up ...Man This Whole board is loaded with those elites in the business ..and are Part of these committee hearings with New FDA MAKARY /ties. https://candeltx.com/about/
1 · Reply
Latest News on CADL
Candel Therapeutics to Present at Upcoming Investor Conferences

May 6, 2025, 8:05 AM EDT - 4 months ago

Candel Therapeutics to Present at Upcoming Investor Conferences


Candel Therapeutics: Entering Its Pivotal Year

Feb 20, 2025, 10:45 AM EST - 7 months ago

Candel Therapeutics: Entering Its Pivotal Year


Best-Performing Stocks Of 2024

Jan 2, 2025, 11:46 PM EST - 9 months ago

Best-Performing Stocks Of 2024

APP BYRN DAVE INOD JANX LUNR MSTR


Candel Therapeutics Announces Pricing of Public Offering

Dec 12, 2024, 11:00 PM EST - 9 months ago

Candel Therapeutics Announces Pricing of Public Offering


Candel Therapeutics Stock Surges Over 100% - Here's Why

Dec 11, 2024, 9:19 AM EST - 9 months ago

Candel Therapeutics Stock Surges Over 100% - Here's Why


Candel Therapeutics' cancer drug meets late-stage trial goals

Dec 11, 2024, 7:09 AM EST - 9 months ago

Candel Therapeutics' cancer drug meets late-stage trial goals


3 Biotech Names With Potential Catalysts By Year End

Jul 29, 2024, 3:32 PM EDT - 1 year ago

3 Biotech Names With Potential Catalysts By Year End

RCKT VRDN


Candel Therapeutics to Join Russell 3000® Index

Jun 11, 2024, 8:00 AM EDT - 1 year ago

Candel Therapeutics to Join Russell 3000® Index


MoneyGroupLLC
MoneyGroupLLC Sep. 14 at 1:13 AM
Enter: $CADL OCT 17 2025 $5 CALLS Buy in Price: $0.40 - $1.50 Take Profit: $0.52 Stop Bleeding: $0.35 ROI Potential: 29% Exit Within: 25 Minutes https://moneygroup.us/alerts
0 · Reply
fishmom
fishmom Sep. 13 at 7:01 PM
$CADL First and foremost, we are investors in a venture for both financial and humanitarium purposes. Thus, help people and have good investment for our relative futures. Self life is important as well as storage requirements and anything that helps these objectives are only relevant to those who are not consistent with the needs of being in the marketplace for stockholders. Patience for all potential expressions of the underlying medical processes are the most important, so be patient and wait for a partner news.
1 · Reply
Husky007
Husky007 Sep. 13 at 3:41 PM
$CADL here's another twist, so the company announced the results of prostate cancer trial December 11th 2024, if the management would have started the manufacturing process then they would have been able to file bla probably January 2026 12 month by the latest give and take 1 or 2 months. But for some reason we're delayed to December 2026 something doesn't add up here. So my theory is they're probably going for 18 months instead of 12 months and 6 months.
1 · Reply
telomerase
telomerase Sep. 13 at 2:51 PM
$CADL here's an interesting calculation... how many thousands of prostate cancer patients will die, have prostatectomies, be chemically castrated etc. because of the delay so that we can claim a longer shelf life on the vector? How about we just ship the product with a six month shelf life and then do a follow-up study to see how much it can be extended? Is the new FDA really this inflexible? Makary claims they aren't... maybe the expensive consultant firm could, you know, ask him.
1 · Reply
itsmejeremy
itsmejeremy Sep. 13 at 2:27 PM
$CADL welcome the newest bag holder 😂 please buy so he can exit without a loss
1 · Reply
Musky49
Musky49 Sep. 13 at 1:00 PM
$CADL Just a reminder that Jacob is pro Candel. The discussion that resulted was beneficial and demonstrated that we have a reputable leader at the helm.
2 · Reply
ShadowBull3745
ShadowBull3745 Sep. 13 at 11:23 AM
$CADL Excellent analysis by DiamondDog33. CADL cares about long term value for its shareholders (board and executive team are significant shareholders as well) and they know the steep value creation will come if they stay focused on execution for now. BP cares about assets that are completely derisked and they are willing to pay much more after approval. It’s obvious what the best strategy is for both CADL and BP.
2 · Reply
deporte1800
deporte1800 Sep. 13 at 9:47 AM
$CADL There are two short-term options regarding the share price: - That PBM attempts to raise the share price in order to execute the warrants before November 13. - Or that large shareholders and institutions keep the share price very low to prevent PBM from exercising the warrants. All of this may have been agreed upon in advance, which is why the $15 million offer was made weeks ago. PBM, Fidelity, the CEO, and other Candel directors accepted the offer at a price of $4.67, with the intention of not diluting the more than 6 million warrants that PBM would be entitled to exercise if certain prices are reached or a purchase offer is made by a BP. We will soon know the planned strategy, so stay tuned!
1 · Reply
DiamondDog33
DiamondDog33 Sep. 13 at 3:25 AM
$CADL PREDICTION- THE JEFFRIES 2025 LONDON Health conference is Nov 18-20 ......Looking for them to ((Initiate))< with similar targets to Cantor Citi Zacks,HWC 19-25 based on approval !!!!! LONG TERM VAL ...In addition they will see the GLIO DATA ...Falls in line with the ER report timeline as well .... 4Q back to rising 50/200 - low 5.86 -6.45.. loading 30 RSI fists over sub5 we shall see if i nail this timing for SWING shrs lot<.
0 · Reply
DiamondDog33
DiamondDog33 Sep. 13 at 12:22 AM
$CADL JUNE is now up ...Man This Whole board is loaded with those elites in the business ..and are Part of these committee hearings with New FDA MAKARY /ties. https://candeltx.com/about/
1 · Reply
DiamondDog33
DiamondDog33 Sep. 13 at 12:19 AM
$CADL ANYBODY THAT HAS BEEN TRADING LAST 20 yrs ... Can you remember a BLA READY CANCER CO trading at 40pct CASH < that had 2 PLATFORMS?? moving ? w/multiple late stage indications.. I have been looking at my logs and cannot find but 1 .....and I still need to do more homework on the their balance sheet just to confirm 100pct. Pretty unbelievable ....<<<<Even my EXEL at this stage prior to CABO approval was not this STACKED. If it gets REALLY REALLY stupid low 4s 200-220 mil ...as we get nearer and nearer.....I will sell big boys ..NVDA APPL and ADD 150K-175K more sh .. better than Manning and Papa level.. JOSEPH AINT NO DUMMY!!!! HE KNOWS what they have... That would be beyond incredible. APPROVAL < valuation 5x and its going to be one Nice Beach Villa one day.< MMS keep up the algo stupidity..on full round trip of insiders level from 7.25 ... buying and cash infusion and WAY BELOW RMAT area of 5.60-5.80
1 · Reply
wrengler4
wrengler4 Sep. 13 at 12:14 AM
$CADL it is not at $4.79 , because it is a winner . Hahahahaha
0 · Reply
wrengler4
wrengler4 Sep. 13 at 12:13 AM
$CADL another lie !!!! guy across the street , has no diaper , and I don’t go to bed with him. Hahaha But your beliefs have. TRUMP theme to them , LIES
0 · Reply
apatbeck79
apatbeck79 Sep. 13 at 12:06 AM
$CADL accumulate below 5. Always bounces back to 5.30-6.00. The game is here to play and I’m a player in it
0 · Reply
itsmejeremy
itsmejeremy Sep. 12 at 10:51 PM
$CADL time kills all deals. Shareholders are paying for taks greed. And he expects $15 billion after all the novice mistakes he’s made? what an arrogant tool
0 · Reply
itsmejeremy
itsmejeremy Sep. 12 at 10:45 PM
$CADL $3 coming next mark it
0 · Reply
DiamondDog33
DiamondDog33 Sep. 12 at 10:29 PM
$CADL JACOB THE MORON has a HARD TIME UNDERSTANDING ENGLISH .... Now Move on .......to write more misinformation elsewhere......
0 · Reply
Xanderzzzzzzz
Xanderzzzzzzz Sep. 12 at 10:20 PM
2 · Reply
profitraider
profitraider Sep. 12 at 9:04 PM
$CADL Told you… everyone laughed at me when I said this would break into the 4’s! I hope you learned your lesson!
1 · Reply
bourbonboy32
bourbonboy32 Sep. 12 at 8:54 PM
$CADL 3s are coming if he dont announce a partnership!! Shorted to hell and back
2 · Reply
itsmejeremy
itsmejeremy Sep. 12 at 8:17 PM
$CADL lmao almost back under the SECOND offering price! Great job Tak! 🤡
0 · Reply
itsmejeremy
itsmejeremy Sep. 12 at 8:16 PM
$CADL it’s called DEAD money for the next 3 years 😂
0 · Reply